Literature DB >> 11435938

Compartmentalized tau hyperphosphorylation and increased levels of kinases in transgenic mice.

J Götz1, R M Nitsch.   

Abstract

The formation of neurofibrillary tangles in Alzheimer's disease is preceded by a pretangle stage of hyperphosphorylated tau. To characterize pretangle tau in vivo, we correlated, in human tau transgenic mice, levels of kinases known to phosphorylate tau in vitro with the phosphorylation of tau at specific epitopes. Levels of cyclin-dependent kinase-5 were increased in axons of CA1 pyramidal neurons, where tau was phosphorylated specifically at the AD2 epitope Ser396/Ser404. The 12E8 epitope serine262/serine356 and the AT180 epitope threonine231/serine235 were phosphorylated in dendrites, and colocalized with increased levels of glycogen synthase kinase-3. CA1 neurons phosphorylated tau at more epitopes than dentate gyrus neurons, suggesting that tau phosphorylation is cell type-specific, a possible explanation for the spatial distribution of neurofibrillary tangles.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435938     DOI: 10.1097/00001756-200107030-00045

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

Review 1.  Tau-targeted treatment strategies in Alzheimer's disease.

Authors:  Jürgen Götz; Arne Ittner; Lars M Ittner
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Recent rodent models for Alzheimer's disease: clinical implications and basic research.

Authors:  Nady Braidy; Pablo Muñoz; Adrian G Palacios; Gloria Castellano-Gonzalez; Nibaldo C Inestrosa; Roger S Chung; Perminder Sachdev; Gilles J Guillemin
Journal:  J Neural Transm (Vienna)       Date:  2011-11-16       Impact factor: 3.575

3.  Role for glyoxalase I in Alzheimer's disease.

Authors:  Feng Chen; M Axel Wollmer; Frederic Hoerndli; Gerald Münch; Björn Kuhla; Evgeny I Rogaev; Magdalini Tsolaki; Andreas Papassotiropoulos; Jürgen Götz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-05       Impact factor: 11.205

Review 4.  Modes of Aβ toxicity in Alzheimer's disease.

Authors:  Jürgen Götz; Anne Eckert; Miriam Matamales; Lars M Ittner; Xin Liu
Journal:  Cell Mol Life Sci       Date:  2011-06-25       Impact factor: 9.261

Review 5.  New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc.

Authors:  C Corona; A Pensalfini; V Frazzini; S L Sensi
Journal:  Cell Death Dis       Date:  2011-06-23       Impact factor: 8.469

Review 6.  ENU mutagenesis screen to establish motor phenotypes in wild-type mice and modifiers of a pre-existing motor phenotype in tau mutant mice.

Authors:  Xin Liu; Michael Dobbie; Rob Tunningley; Belinda Whittle; Yafei Zhang; Lars M Ittner; Jürgen Götz
Journal:  J Biomed Biotechnol       Date:  2011-12-15

7.  Calmodulin Binding Proteins and Alzheimer's Disease.

Authors:  Danton H O'Day; Kristeen Eshak; Michael A Myre
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  An update on the toxicity of Abeta in Alzheimer's disease.

Authors:  Jürgen Götz; Lars M Ittner; Nicole Schonrock; Roberto Cappai
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

9.  Animal models for Alzheimer's disease and frontotemporal dementia: a perspective.

Authors:  Jürgen Götz; Naeman N Götz
Journal:  ASN Neuro       Date:  2009-11-09       Impact factor: 4.146

Review 10.  Cyclin-dependent kinase 5, a node protein in diminished tauopathy: a systems biology approach.

Authors:  John F Castro-Alvarez; S Alejandro Uribe-Arias; Daniel Mejía-Raigosa; Gloria P Cardona-Gómez
Journal:  Front Aging Neurosci       Date:  2014-09-01       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.